1. Home
  2. WTFC vs CORT Comparison

WTFC vs CORT Comparison

Compare WTFC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTFC

Wintrust Financial Corporation

HOLD

Current Price

$142.20

Market Cap

9.5B

Sector

Finance

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$79.98

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTFC
CORT
Founded
1991
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WTFC
CORT
Price
$142.20
$79.98
Analyst Decision
Strong Buy
Buy
Analyst Count
12
6
Target Price
$154.67
$130.20
AVG Volume (30 Days)
484.5K
999.2K
Earning Date
01-20-2026
11-04-2025
Dividend Yield
1.40%
N/A
EPS Growth
13.95
N/A
EPS
10.89
0.87
Revenue
$2,563,182,000.00
$741,172,000.00
Revenue This Year
$17.85
$23.96
Revenue Next Year
$5.85
$43.40
P/E Ratio
$13.16
$94.62
Revenue Growth
13.69
17.92
52 Week Low
$89.10
$49.00
52 Week High
$144.70
$117.33

Technical Indicators

Market Signals
Indicator
WTFC
CORT
Relative Strength Index (RSI) 59.59 45.62
Support Level $142.44 $80.38
Resistance Level $143.97 $85.34
Average True Range (ATR) 2.38 3.36
MACD -0.09 -0.65
Stochastic Oscillator 67.08 16.79

Price Performance

Historical Comparison
WTFC
CORT

About WTFC Wintrust Financial Corporation

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: